In 2020, 34.2 million people in the United States were diagnosed with diabetes—10.5% of the population. Diabetes impacts patients of all social, economic and ethnic backgrounds. It was the seventh leading cause of death in 2017, and the total estimated costs of diagnosed diabetes was $327 billion that year. These numbers have been rising steadily in the past decade, and during the pandemic, it became apparent just how much having diabetes, especially uncontrolled diabetes, impacts patient outcomes in almost every other comorbid condition.
This year, C3 is putting diabetes care at the center of our scorecard. We believe that by focusing on diabetic outcomes, and ensuring these patients are well-supported and taken care of, we can not only improve a broad range of clinical outcomes, but also create savings in our value-based contracts. This quarter’s newsletter offers a range of tips for success as we do this work. We hope you find it valuable for both you and your patients.
Source: Centers for Disease Control National Diabetes Statistics Report 2020; National Institutes of Health